Company intelligence / Profile preview

OSSIO

Woburn, Massachusetts, United Statesossio.io ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

OSSIOfiber implants have been used in over 50,000 procedures since their commercial launch in 2019. Clinical studies report high patient satisfaction and successful bone integration without the need for permanent hardware removal. The technology has demonstrated superior strength and bio-integration compared to traditional metal or bio-composite implants.

Therapeutic areas: OtherRheumatology
Modalities: DeviceImplant
Industry: Implantable Medical Devices

Partnerships

Distribution partners in the U.S.; no major pharma partnerships disclosed as of June 2025.

Beyond the preview

Go deeper on OSSIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OSSIO.

Explore the full profile